CoreAgeRx vs RxActivate: Pricing Transparency and Intake Differences

CoreAgeRx vs RxActivate: if you want clear upfront pricing, CoreAgeRx provides flat monthly fees; RxActivate requires an eligibility flow and contact information before showing prices. Early verdict: CoreAgeRx is more transparent on cost, while RxActivate gates pricing behind intake and clinician matching.

How the two compare at a glance

This comparison focuses on the most distinctive differences supported by the source: pricing transparency and structure, intake and eligibility flow, medication dose details and claims, and required clinician review and regulatory notes. Both providers require clinician determination that treatment is medically appropriate.

1. Pricing transparency and billing terms

CoreAgeRx advertises flat monthly pricing with specific amounts for two medications: semaglutide at $79 per month and tirzepatide at $129 per month, and emphasizes “Same Price. Every Month.” CoreAgeRx also states no membership fee and no price hikes. By contrast, RxActivate does not display price or billing terms before the contact-information gate; pricing is gated behind completion of the eligibility questionnaire and submission of name, email and phone number.

Start RxActivate eligibility quiz

2. Intake and eligibility flow

CoreAgeRx: the landing information notes a 3-minute online visit and that no insurance is required. RxActivate: the flow is a two-minute eligibility questionnaire that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. RxActivate displayed likely eligibility in testing but required contact details before revealing plan or price.

3. Medication dose details and claims

CoreAgeRx lists dose ranges: tirzepatide up to 7.5 mg and semaglutide up to 1.0 mg. It includes a patient testimonial quoted on the landing page. RxActivate describes clinician-matched GLP-1 plans but captured evidence does not list specific dose ranges or public outcome data in the captured material. Both sources include the qualifier that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality.

4. State availability and verification

CoreAgeRx notes that pricing, eligibility, pharmacy, state coverage and renewal terms may change and recommends confirming eligibility, medication, total cost, renewal terms and state availability before enrollment. RxActivate captured evidence included a synthetic test confirming Alabama availability and states that eligibility and state screening are part of the flow.

Comparison table: CoreAgeRx vs RxActivate

What this means for you

If transparent, upfront pricing is your priority, CoreAgeRx provides explicit monthly fees and emphasizes no membership or hidden fees in the captured landing information. If you prefer to be clinician-matched first and are willing to provide contact information before seeing price, RxActivate requires the eligibility questionnaire and contact gate before revealing plan and pricing details.

Proceed with RxActivate intake

Choose one based on documented differences

Choose CoreAgeRx if you need clear, listed monthly pricing for semaglutide ($79/mo) or tirzepatide ($129/mo), prefer a stated flat monthly price and want pricing visible before enrollment. Choose RxActivate if you accept that pricing and plan details are gated behind a clinician eligibility flow and you want clinician-matched GLP-1 plans revealed after completing the intake and contact steps. Both require clinician review and advise confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.